PD-1 INHIBITOR
Clinical trials for PD-1 INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PD-1 INHIBITOR trials appear
Sign up with your email to follow new studies for PD-1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation combo aims to boost immunotherapy in advanced lung cancer
Disease control OngoingThis early-phase trial tests whether adding low-dose radiation and targeted radiation (SBRT) to an immunotherapy drug (PD-1 inhibitor) is safe for people with stage IV non-small cell lung cancer who have not responded to standard treatments. About 9 participants will receive the …
Matched conditions: PD-1 INHIBITOR
Phase: PHASE1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Gut bacteria boost? new trial tests probiotics to help immunotherapy fight stubborn colorectal cancer
Disease control OngoingThis early-phase study tests whether adding Akkermansia probiotics to standard immunotherapy and chemotherapy can safely help patients with advanced colorectal cancer that hasn't responded to prior treatments. The trial enrolls 22 adults whose tumors are MSS/pMMR type, which typi…
Matched conditions: PD-1 INHIBITOR
Phase: NA • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Immunotherapy plus chemo shows promise against tough throat cancer
Disease control OngoingThis phase 2 trial tests whether adding a PD-1 inhibitor (a type of immunotherapy) to standard chemotherapy before radiation can improve outcomes for people with advanced nasopharyngeal carcinoma. About 150 participants will receive either the combination or chemotherapy alone, f…
Matched conditions: PD-1 INHIBITOR
Phase: PHASE2 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC